SCHEMBL17127019

SCHEMBL17127019

CCOCCSC(C(=O)c1ccc(Oc2ccc(OCC)cc2)cc1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PARP10 Q53GL7 1/20 0.40
▸ LTA4H P09960 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ PLK1 P53350 1/20 0.39
▸ NPSR1 Q6W5P4 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ THRA P10827 1/20 0.38
▸ SLC2A1 P11166 1/20 0.37
▸ PLA2G4B P0C869 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126973 0.91 SMN1; SMN2 (0.43) LMNAHTTSMN1; SMN2PARP10ALDH1A1
SCHEMBL17126976 0.91 PPARA (0.40) RAB9ASMN1; SMN2PARP10LTA4HNPC1
SCHEMBL17777239 0.89 SLC2A1 (0.48) SMN1; SMN2ALDH1A1HPGDTHRASLC2A1
SCHEMBL17127023 0.88 KDM4E (0.37) LMNAHTTRAB9APAX8ATM
SCHEMBL17127021 0.88 KDM4E (0.34) LMNAHTTRAB9APAX8ATM
SCHEMBL17126977 0.87 PARP10 (0.44) LMNAHTTRAB9APAX8ATM
SCHEMBL15935680 0.86 SMN1; SMN2 (0.46) LMNAHTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL17127365 0.86 PARP10 (0.45) LMNAHTTRAB9APAX8ATM
SCHEMBL17126863 0.86 ACACB (0.37) LMNASMN1; SMN2LTA4HPLK1MAPT
SCHEMBL17127025 0.86 PARP10 (0.43) LMNAHTTRAB9APAX8ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS LMNA 2937/4885HTT 1863/4885RAB9A 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback